Use of antipsychotics and antidepressants in patients with HIV
Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms a...
Saved in:
Published in | European psychiatry Vol. 33; no. S1; pp. S150 - S151 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Masson SAS
01.03.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions. |
---|---|
AbstractList | Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy.
Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection.
PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials.
Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics.
Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions. Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions. Disclosure of interest The authors have not supplied their declaration of competing interest. Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with general population arises to 37%. Psychotic symptoms in patients with HIV are a very frequent entity, in some cases, these symptoms are pre-existent in others the evolution of the infection or a medical cause related with the infection can cause its apparition. Psychosis and depression in patients with HIV have some clinical and therapeutical considerations. Antidepressants and antipsychotics have many pharmacological interactions with antiretroviral therapy. Objectives Review the efficacy and safety of antidepressants and antipsychotics in patients with HIV infection. Methods PubMed was searched for articles published between 1966 and January 1, 2015, using the search terms HIV, AIDS, depression, phycosis, antipsychotics, antidepressants, antiretrovirals. We selected randomized placebo controlled or active comparator control trials. Results Twelve studies for depression treatment and 2 studies for psychosis treatment in patients with HIV infection. Selective serotonin reuptake inhibitors (SSRI) especially fluoxetine and tryciclic antidepressants are effective in treating depressive symptoms in patients with HIV infection. Testosterone and stimulants have been used in patients with mild depressive symptoms, however studies with these agents had a small sample size. Haloperidol and chlorpromazine were effective for AIDS delirium, there are not controlled trials with other antipsychotics. Conclusions Psychiatrists must be concern about the clinical particularities of patients with HIV and depression or psychotic symptoms. The election of antidepressant or antipsychotic has to be made very carefully because of their side effects and interactions. |
Author | Rodriguez Criado, N Bravo Herrero, S Sánchez Sánchez, B García Sánchez, F Martín Aragón, R Cruz Fourcade, J.F Muñoz-Calero, P |
Author_xml | – sequence: 1 fullname: Muñoz-Calero, P – sequence: 2 fullname: García Sánchez, F – sequence: 3 fullname: Rodriguez Criado, N – sequence: 4 fullname: Martín Aragón, R – sequence: 5 fullname: Cruz Fourcade, J.F – sequence: 6 fullname: Bravo Herrero, S – sequence: 7 fullname: Sánchez Sánchez, B |
BookMark | eNqVkEFOwzAQRS1UJFrgBixygQSPncTOphKqgFaqxILC1nLsiepQkshOQb09DuUCrGb-aP7XzFuQWdd3SMgd0AwolPdthkc_hFPGosooZEzABZmDEDLlhSxmZE4rlqcV5_KKLEJoKQVBaTkny7eASd8kuhtdTDD7fnQmRGl_RxYHjyHENiSuSwY9Opz6bzfuk_Xm_YZcNvoQ8PavXpPd0-NutU63L8-b1cM2NaxgkFasZGUtpRS2rDhUubBVnXPGoJY1Ssosz2lc1UwbsMiLxsgGrKybvABR82uSn2ON70Pw2KjBu0_tTwqomhCoVp0RqAmBoqAigmhbnm0YT_ty6FUw8X6D1nk0o7K9-2-AObjOGX34wBOGtj_6Lr6tQAWmqHqdKE-QoaSUiYLzH6X6fUA |
CitedBy_id | crossref_primary_10_1186_s13104_019_4398_6 |
ContentType | Journal Article |
Copyright | 2016 |
Copyright_xml | – notice: 2016 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.eurpsy.2016.01.271 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1778-3585 |
EndPage | S151 |
ExternalDocumentID | 10_1016_j_eurpsy_2016_01_271 S0924933816002753 1_s2_0_S0924933816002753 |
GroupedDBID | --- --K --M .1- .FO .~1 09C 09E 0R~ 0SF 1B1 1P~ 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8FI 8FJ 8P~ AABNK AACTN AAEDT AAEDW AAFWJ AAIKJ AAKOC AALRI AANRG AAOAW AAQXK AASVR AAXUO ABBQC ABBZL ABFNM ABIVO ABJNI ABMZM ABUWG ABVZP ABXAU ABXDB ACDAQ ACGFS ACHQT ACIUM ACQPF ACZWT ADAZD ADBBV ADDNB ADEZE ADKIL ADMUD ADOVH ADVJH ADVLN AEBAK AEKER AENCP AENEX AEVXI AEYHU AFCTW AFKRA AFRHN AFTJW AGABE AGHFR AGJUD AGUBO AGYEJ AHIPN AHRGI AITUG AJOXV AJPFC AJRQY AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AQJOH ASPBG AVWKF AZFZN AZQEC BENPR BLXMC BLZWO CCPQU CCQAD CCUQV CFBFF CGQII CJCSC CS3 CTKSN DOHLZ DU5 DWQXO EBS EGQIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYUFA G-Q GBLVA GNUQQ GROUPED_DOAJ HVGLF HZ~ IHE IKXGN IOO IPYYG J1W LN9 M2M M41 MO0 N9A NCXOZ NZEOI O-L O9- OAUVE OH0 OK1 OU- OZT P-8 P-9 P2P PC. PIMPY PSYQQ Q38 R2- RCA RIG ROL RPM RPZ SCC SDF SDG SDP SES SEW SSZ T5K UHS UKHRP UV1 WFFJZ Z5R ~G- AAEED AAQFI ABYKQ AEBPU AFPKN AJBFU EFLBG LCYCR LW7 AAYXX CITATION |
ID | FETCH-LOGICAL-c2521-92626b8887d6931947d9b43221b8be802d340c25a2ac1de35fc8f1d8bf4517b3 |
IEDL.DBID | .~1 |
ISSN | 0924-9338 |
IngestDate | Thu Sep 26 16:14:40 EDT 2024 Fri Feb 23 02:30:52 EST 2024 Tue Oct 15 23:01:34 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S1 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2521-92626b8887d6931947d9b43221b8be802d340c25a2ac1de35fc8f1d8bf4517b3 |
OpenAccessLink | https://www.cambridge.org/core/services/aop-cambridge-core/content/view/106663DF136F5AADDDD7E62883DC20C4/S0924933800224759a.pdf/div-class-title-use-of-antipsychotics-and-antidepressants-in-patients-with-hiv-div.pdf |
ParticipantIDs | crossref_primary_10_1016_j_eurpsy_2016_01_271 elsevier_sciencedirect_doi_10_1016_j_eurpsy_2016_01_271 elsevier_clinicalkeyesjournals_1_s2_0_S0924933816002753 |
PublicationCentury | 2000 |
PublicationDate | March 2016 |
PublicationDateYYYYMMDD | 2016-03-01 |
PublicationDate_xml | – month: 03 year: 2016 text: March 2016 |
PublicationDecade | 2010 |
PublicationTitle | European psychiatry |
PublicationYear | 2016 |
Publisher | Elsevier Masson SAS |
Publisher_xml | – name: Elsevier Masson SAS |
SSID | ssj0017006 |
Score | 2.155413 |
Snippet | Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in... Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in comparison with... Introduction Psychological distress appears in the majority of people infected with HIV. Depression is the most important affection, the prevalence in... |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | S150 |
SubjectTerms | Internal Medicine Psychiatry |
Title | Use of antipsychotics and antidepressants in patients with HIV |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0924933816002753 https://dx.doi.org/10.1016/j.eurpsy.2016.01.271 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELaqDogF8RTlUXlgDbUdO48FCVVUBakstKibFceOFIa0ImVg4bdzlzioCMSAlMWRrSSffXe-83cXQq6sASPrWBokMucYuuFBZooMwxwuFMpKZjCgP3uMpgv5sFTLHhl3uTBIq_S6v9Xpjbb2d0YezdG6LEdPDF2HEA--0LdSWPFTgvmDNX398UXzwPJzzXkldA6wd5c-13C8HHxM_Y4ErwiLd4qY_26etkzOZJ_s-b0ivW1f54D0XHVIdmb-NPyI3CxqR1cFBXBKn01V5jU0bXPLk1yR6ELLivoKqjXF0Cud3j8fk_nkbj6eBv5_CEEuFDIpBHgfBlzW2EYpiI6MbWokSCQ3iXEJEzaUDLpmIsu5dSHSswpuE1NIxWMTnpB-tarcKaEgyJESRQruFpOxyo2ACSrgcklhIpUNSNChoNdt1Qvd0cFedIuaRtQ04xpQG5C4g0p3GZ2gg1ztBaLWXNdCM_1j0rZHfpt3DSr9z2ee_XvkOdnFVsskuyD9zeubu4StxcYMm7UzbBzzT_KAzLE |
link.rule.ids | 315,783,787,867,4509,27936,27937,45597 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZKkYAF8RTlmYE1NHbsPBYkVFGl0HahRd2sOHakMLQVKQMLv527xEFFIAakLHFsxfnsO_vO310IudYKFlnjxW7EM4quG-qmKk_RzWF8JjT3FDr0R-MgmfKHmZi1SK-JhUFapdX9tU6vtLUt6Vo0u8ui6D55aDr4ePCFtpXwN8gmx_0xTOqbjy-eB-afqw4sobaL1Zv4uYrkZeBryndkeAWYvZOF9Pf1aW3N6e-RXbtZdO7q_uyTlpkfkK2RPQ4_JLfT0jiL3AF0ChtOVWQl3OqqyLJckeniFHPHplAtHfS9Osng-YhM-veTXuLaHyK4GRNIpWBgfiiwWUMdxCA7PNSx4iCSVEXKRB7TPvegasrSjGrjIz8rpzpSORc0VP4xac8Xc3NCHJDkQLA8BnvL46HIFIMRyuEyUa4CkXaI26Agl3XaC9nwwV5kjZpE1KRHJaDWIWEDlWxCOkEJmdJKRCmpLJn05I9RW2_5beAl6PQ_33n675ZXZDuZjIZyOBg_npEdfFLTys5Je_X6Zi5gn7FSl9U8-gSIac7j |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+antipsychotics+and+antidepressants+in+patients+with+HIV&rft.jtitle=European+psychiatry&rft.au=Mu%C3%B1oz-Calero%2C+P.&rft.au=Garc%C3%ADa+S%C3%A1nchez%2C+F.&rft.au=Rodriguez+Criado%2C+N.&rft.au=Mart%C3%ADn+Arag%C3%B3n%2C+R.&rft.date=2016-03-01&rft.issn=0924-9338&rft.eissn=1778-3585&rft.volume=33&rft.issue=S1&rft.spage=S150&rft.epage=S151&rft_id=info:doi/10.1016%2Fj.eurpsy.2016.01.271&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_eurpsy_2016_01_271 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09249338%2FS0924933816X00041%2Fcov150h.gif |